Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 1999, p. 763-768, Vol. 43, No. 4
Department of Pathobiology, School of Public
Health and Community Medicine, University of Washington, and the
Seattle Biomedical Research Institute, Seattle, Washington
Received 17 September 1998/Returned for modification 23 December
1998/Accepted 13 January 1999
Oral infections caused by the yeast Candida albicans
are some of the most frequent and earliest opportunistic infections in human immunodeficiency virus-infected patients. The widespread use of
azole antifungal drugs has led to the development of drug resistance,
creating a major problem in the treatment of yeast infections in AIDS
patients and other immunocompromised individuals. Several molecular
mechanisms that contribute to drug resistance have been identified. In
C. albicans, the ability to morphologically switch from
yeast cells (blastospores) to filamentous forms (hyphae) is an
important virulence factor which contributes to the dissemination of
Candida in host tissues and which promotes infection and
invasion. A positive correlation between the level of antifungal drug
resistance and the ability to form hyphae in the presence of azole
drugs has been identified. Under hypha-inducing conditions in the
presence of an azole drug, resistant clinical isolates form hyphae,
while susceptible yeast isolates do not. This correlation is observed in a random sample from a population of susceptible and resistant isolates and is independent of the mechanisms of resistance.
35S-methionine incorporation suggests that growth
inhibition is not sufficient to explain the inhibition of hyphal
formation, but it may contribute to this inhibition.
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Effects of Azole Antifungal Drugs on the Transition
from Yeast Cells to Hyphae in Susceptible and Resistant Isolates of the
Pathogenic Yeast Candida albicans
*
Corresponding author. Mailing address: Seattle
Biomedical Research Institute, 4 Nickerson St., Suite 200, Seattle, WA
98109-1651. Phone: (206) 284-8846, ext. 344. Fax: (206) 284-0313. E-mail: tedwhite{at}u.washington.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»